Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Current Taxes (2021 - 2022)

Historic Current Taxes for Cartesian Therapeutics (RNAC) over the last 2 years, with Q2 2022 value amounting to $320000.0.

  • Cartesian Therapeutics' Current Taxes changed N/A to $320000.0 in Q2 2022 from the same period last year, while for Jun 2022 it was $320000.0, marking a year-over-year change of. This contributed to the annual value of $601000.0 for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q2 2022, Cartesian Therapeutics' Current Taxes is $320000.0.
  • Cartesian Therapeutics' Current Taxes' 5-year high stood at $15.8 million during Q3 2021, with a 5-year trough of $320000.0 in Q1 2022.